Cargando…

Statistical issues in drug development /

Drug development is the process of finding and producing therapeutically useful pharmaceuticals, turning them into safe and effective medicine, and producing reliable information regarding the appropriate dosage and dosing intervals. With regulatory authorities demanding increasingly higher standard...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Senn, Stephen
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Chichester, England ; Hoboken, NJ : John Wiley & Sons, ©2007.
Edición:2nd ed.
Colección:Statistics in practice.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 EBOOKCENTRAL_ocn646751242
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cn|||||||||
008 071101s2007 enka ob 001 0 eng d
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCQ  |d N$T  |d BTCTA  |d IDEBK  |d UBY  |d STF  |d OCLCQ  |d OCLCF  |d OCLCQ  |d NLGGC  |d OCLCO  |d YDXCP  |d DG1  |d EBLCP  |d MERUC  |d UKDOC  |d OCLCQ  |d COO  |d OCLCQ  |d DEBBG  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d IAS  |d OCLCO  |d OCLCQ  |d COCUF  |d DG1  |d CHVBK  |d OCLCO  |d OCLCQ  |d LIP  |d OCLCO  |d PIFAG  |d ZCU  |d OCLCO  |d OCLCQ  |d U3W  |d OCLCQ  |d WRM  |d OCLCQ  |d NRAMU  |d ICG  |d INT  |d VT2  |d AU@  |d OCLCQ  |d TXC  |d WYU  |d OCLCA  |d OCLCQ  |d DKC  |d OCLCQ  |d OL$  |d OCLCQ  |d OCLCA  |d UKCRE  |d OCLCQ  |d OCLCO  |d OCL  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |z 101319993  |2 DNLM 
019 |a 214282044  |a 216937168  |a 244095090  |a 437218706  |a 476172339  |a 505101693  |a 698472375  |a 709567822  |a 961525987  |a 962723721  |a 966253738  |a 991913438  |a 1037758515  |a 1038672327  |a 1045497316  |a 1055406219  |a 1066608757  |a 1077241876  |a 1081207425  |a 1153499879  |a 1228534255 
020 |a 9780470723579  |q (electronic bk.) 
020 |a 0470723572  |q (electronic bk.) 
020 |a 9780470723586 
020 |a 0470723580 
020 |z 9780470018774  |q (cloth ;  |q alk. paper) 
020 |z 0470018771  |q (cloth ;  |q alk. paper) 
024 7 |a 10.1002/9780470723586  |2 doi 
029 1 |a AU@  |b 000061122529 
029 1 |a CHNEW  |b 000935809 
029 1 |a CHVBK  |b 480160902 
029 1 |a DEBBG  |b BV043391556 
029 1 |a DEBBG  |b BV044130143 
029 1 |a DEBSZ  |b 484986589 
029 1 |a NLGGC  |b 314157395 
029 1 |a NZ1  |b 13341061 
035 |a (OCoLC)646751242  |z (OCoLC)214282044  |z (OCoLC)216937168  |z (OCoLC)244095090  |z (OCoLC)437218706  |z (OCoLC)476172339  |z (OCoLC)505101693  |z (OCoLC)698472375  |z (OCoLC)709567822  |z (OCoLC)961525987  |z (OCoLC)962723721  |z (OCoLC)966253738  |z (OCoLC)991913438  |z (OCoLC)1037758515  |z (OCoLC)1038672327  |z (OCoLC)1045497316  |z (OCoLC)1055406219  |z (OCoLC)1066608757  |z (OCoLC)1077241876  |z (OCoLC)1081207425  |z (OCoLC)1153499879  |z (OCoLC)1228534255 
037 |a 10.1002/9780470723586  |b Wiley InterScience  |n http://www3.interscience.wiley.com 
050 4 |a RM301.25  |b .S46 2007eb 
060 4 |a 2008 B-684 
060 4 |a QV 771  |b S478s 2007 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
082 0 4 |a 615/.190727  |2 22 
084 |a 44.38  |2 bcl 
084 |a 44.32  |2 bcl 
049 |a UAMI 
100 1 |a Senn, Stephen. 
245 1 0 |a Statistical issues in drug development /  |c Stephen Senn. 
250 |a 2nd ed. 
260 |a Chichester, England ;  |a Hoboken, NJ :  |b John Wiley & Sons,  |c ©2007. 
300 |a 1 online resource (xix, 498 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a Statistics in practice 
504 |a Includes bibliographical references and index. 
505 0 |a A brief and superficial history of statistics for drug developers -- Design and interpretation of clinical trials as seen by a statistician -- Probability, Bayes, P-values, tests of hypotheses, and confidence intervals -- The work of the pharmaceutical statistician -- Allocating treatments to patients in clinical trials -- Baselines and covariate information. 
505 0 |a The measurement of treatment effects -- Demographic subgroups : representation and analysis -- Multiplicity -- Intention to treat, missing data and related matters -- One-sided and two-sided tests and other issues to do with significance and P-values -- Determining the sample size -- Multicentre trials -- Active control equivalence studies. 
505 0 |a Meta-analysis -- Cross-over trials -- n-of-1 trials -- Sequential trials -- Dose-finding -- Concerning pharmacokinetics and pharmacodynamics -- Bioequivalence studies -- Safety data, harms, drug monitoring, and pharmaco-epidemiology -- Pharmaco-economics and portfolio management -- Concerning pharmacogenetics, pharmacogenomics, and related matters. 
588 0 |a Print version record. 
520 |a Drug development is the process of finding and producing therapeutically useful pharmaceuticals, turning them into safe and effective medicine, and producing reliable information regarding the appropriate dosage and dosing intervals. With regulatory authorities demanding increasingly higher standards in such developments, statistics has become an intrinsic and critical element in the design and conduct of drug development programmes. Statistical Issues in Drug Development presents an essential and thought provoking guide to the statistical issues and controversies involved in drug development. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Drug development  |x Statistical methods. 
650 0 |a Drugs  |x Design. 
650 2 |a Clinical Trials as Topic 
650 2 |a Drug Design 
650 2 |a Statistics as Topic  |x methods 
650 6 |a Médicaments  |x Développement  |x Méthodes statistiques. 
650 6 |a Médicaments  |x Conception. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a Drugs  |x Design  |2 fast 
650 7 |a Drug development  |x Statistical methods  |2 fast 
650 1 7 |a Statistiek.  |2 gtt  |0 (NL-LeOCL)07867509X 
650 1 7 |a Geneesmiddelen.  |2 gtt  |0 (NL-LeOCL)078516625 
650 1 7 |a Research and Development.  |2 gtt  |0 (NL-LeOCL)078649544 
758 |i has work:  |a Statistical issues in drug development (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGPD94rKvFGY7CXGxT8Jym  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |a Senn, Stephen.  |t Statistical issues in drug development.  |b 2nd ed.  |d Chichester, England ; Hoboken, NJ : John Wiley & Sons, ©2007  |w (DLC) 2007045553 
830 0 |a Statistics in practice. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=351458  |z Texto completo 
938 |a 123Library  |b 123L  |n 3471 
938 |a Baker and Taylor  |b BTCP  |n BK0008165339 
938 |a ebrary  |b EBRY  |n ebr10232744 
938 |a EBSCOhost  |b EBSC  |n 233276 
938 |a YBP Library Services  |b YANK  |n 2854005 
938 |a YBP Library Services  |b YANK  |n 2941310 
994 |a 92  |b IZTAP